Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
University Hospital, Grenoble |
---|---|
Information provided by: | University Hospital, Grenoble |
ClinicalTrials.gov Identifier: | NCT00860106 |
The purpose of this trial is to perform a prospective multicentric study to determine predictive ED score and D-dimer level in the evaluation of the thromboembolic event recurrence after anticoagulant treatment cessation. The patients are included in the study from the anticoagulant treatment cessation. An ED score and a blood sample are performed at this time and one month later. Then, the patients are followed up by phone for 2 years.
Condition | Intervention | Phase |
---|---|---|
Previous Vka Treatment Previous Proximal VTE |
Other: ED, DDimers and phone follow up |
Phase IV |
Study Type: | Interventional |
Study Design: | Prevention, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety Study |
Official Title: | Study of Predictive Echo Doppler Score and D-Dimer Level in Evaluation of the Thromboembolic Event Recurrence After Anticoagulant Treatment Cessation. |
Enrollment: | 222 |
Study Start Date: | March 2005 |
Estimated Study Completion Date: | March 2010 |
Primary Completion Date: | March 2008 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
Follow up
ED score and DDimer level of patients who have stopped their VKA treatment (after the first or the second previous proximal VTE). Phone follow up for 2 years. |
Other: ED, DDimers and phone follow up
ED score, DDimers level and phone questionnary
|
DDimer levels are centralized in University Hospital of Grenoble at the end of the study
Ages Eligible for Study: | 18 Years to 80 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
France | |
Vascular Medecine Departement - University Hospital of Grenoble | |
GRENOBLE, France, 38043 | |
Clinique Mutualiste les eaux claires | |
GRENOBLE, France | |
Cabinet Medical | |
GRENOBLE, France | |
CMC Les Petites Roches | |
SAINT HILAIRE DU TOUVET, France | |
HOSPITAL | |
ANNECY, France | |
HOSPITAL | |
CHAMBERY, France | |
Cabinet Medical | |
GRENOBLE, France | |
Cabinet Medical | |
GRENOBLE, France | |
Cabinet Medical | |
GRENOBLE, France | |
Cabinet Medical | |
GRENOBLE, France | |
Cabinet Medical | |
GRENOBLE, France | |
Cabinet Medical | |
MEYLAN, France | |
Cabinet Medical | |
GRENOBLE, France | |
Cabinet Medical | |
GRENOBLE, France | |
Cabinet Medical | |
VOIRON, France | |
Cabinet Medical | |
ANNECY, France | |
Cabinet Medical | |
FONTAINE, France | |
Cabinet Medical | |
CROLLES, France | |
University Hospital | |
AMIENS, France | |
Cabinet Medical | |
GRENOBLE, France | |
Cabinet Medical | |
BOURGOIN JALLIEU, France | |
Cabinet Medical | |
CHALON SUR SAONE, France | |
Cabinet Medical | |
PONTCHARRA, France | |
Cabinet Medical | |
SAINT EGREVE, France |
Principal Investigator: | Gilles PERNOD, Professor | University Hospital, Grenoble |
Responsible Party: | University Hospital of Grenoble ( Gilles PERNOD / Professor ) |
Study ID Numbers: | DCIC 04 22 |
Study First Received: | March 10, 2009 |
Last Updated: | March 10, 2009 |
ClinicalTrials.gov Identifier: | NCT00860106 History of Changes |
Health Authority: | France: Ministry of Health |
VTE VKA treatment VKA treatment cessation |
Anticoagulants Fibrin fragment D Recurrence |
Anticoagulants Therapeutic Uses Hematologic Agents Pharmacologic Actions |